Advertisement

AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites

  1. Gitte Andersen, PhD (gtta{at}steno.dk)1,
  2. Kristoffer Sølvsten Burgdorf, BSc1,
  3. Thomas Sparsø, MSc1,
  4. Knut Borch-Johnsen, DMSc1,,2,,3,
  5. Torben Jørgensen, DMSc2,
  6. Torben Hansen, PhD1 and
  7. Oluf Pedersen, DMSc1,,3
  1. 1Steno Diabetes Center, Gentofte, Denmark
  2. 2Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
  3. 3Faculty of Health Science, University of Aarhus, Aarhus, Denmark

    Abstract

    Objective: The gene encoding the α2 Heremans-Schmid glycoprotein, AHSG, is a credible biological and positional candidate gene for type 2 diabetes and the metabolic syndrome, and previous attempts to relate AHSG variation with type 2 diabetes and obesity in Swedish and French Caucasians have been largely successful. We related seven frequent AHSG tagSNPs to a range of metabolic traits including type 2 diabetes, obesity, and dyslipidemia.

    Research Design And Methods: The polymorphisms were genotyped in 7,683 Danish whites using Taqman allelic discrimination or chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, providing a statistical power of more than 99% to replicate previous findings. Data were analysed in case-control and haplotype settings, and quantitative metabolic traits were examined for association. Moreover, epistatic effects between AHSG variants and IRS1 and ADRB2 polymorphisms were investigated.

    Results: The −469T>G (rs2077119) and IVS6+98C>T (rs2518136) polymorphisms were associated with type 2 diabetes (P=0.007 and P=0.006, respectively, or Pcorr=0.04 and Pcorr=0.03 following correction for multiple hypothesis testing), and in a combined analysis of the present and a previous study −469T>G remained significant (OR 0.90 [0.84-0.97], P=0.007). Furthermore, two AHSG haplotypes were associated with dyslipidemia (P=0.003, Pcorr=0.009). Thr248Met (rs4917) tended to associate with lower fasting and post-OGTT serum insulin release (P=0.02, Pcorr=0.1 for fasting and P=0.04, Pcorr=0.2 for area under the insulin curve) and improved insulin sensitivity estimated by the homeostasis model assessment of insulin resistance (9.0 mmol/l·pmol/l vs. 8.6 mmol/l·pmol/l, P=0.01, Pcorr=0.06). Indications of epistatic effects of AHSG variants with the IRS1 Gly971Arg polymorphism were observed for fasting serum triglyceride concentrations.

    Conclusions: Based upon present and previous findings common variation in AHSG may contribute to the inter-individual variation in metabolic traits.

    Footnotes

      • Received April 25, 2007.
      • Accepted February 7, 2008.
    Advertisement